FDA Import Refusal AEK-0493626-5/10002/1G — DAEWOONG PHARM CO LTD
The FDA refused shipment AEK-0493626-5/10002/1G from DAEWOONG PHARM CO LTD (South Korea) on Aug 13, 2026. The refused product falls under Drugs and Biologics — ONABOTULINUMTOXINA. Cited charges: 118,472,82 This firm has 3 other import refusals on record.
Refusal details
- Date
- Aug 13, 2026
- Country
- South Korea
- Product Category
- Drugs and Biologics
- Product Code
- 58PCZ05 ONABOTULINUMTOXINA
- Charges
- 118,472,82